Investor Information

 

Theralase® Inc. is a subsidiary of Theralase® Technologies Inc., and is publicly traded on the TSX Venture Exchange (TLT-TSVX) and the OTCQX (TLTFF).

Number of common shares outstanding

Basic: 131,585,526

Warrants: 34,723,839

Options: 5,835,000

Fully Diluted: 172,144,365

Insider Ownership: 6.7% (8.6% fully diluted)

[stockdio-historical-chart]

Financial Filings

 
Downloaded 92 times.
Downloaded 74 times.
Downloaded 50 times.
Downloaded 6 times.
Downloaded 7 times.
Downloaded 2 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 1 times.
Downloaded 1 times.
Downloaded 0 times.
Downloaded 0 times.
Downloaded 1 times.
 
SEDAR Filings (System for Electronic Document Analysis and Retrieval)

Theralase's complete public securities documents are available in English and French on SEDAR.